ocr: Treatment Related Source Study Group Treatment CR (%) Death (%) Outcome DeWitte et al.77 RAEB, RAEB-T; CMML; IDR/A "3+7" 50 8* 11r months DFS age <60 years Estey et al.80 All subtypes FLAG 60 28* 10: months actuarial survival Cheson el al.83 All subtypes LoDAC 16 15* 15 months median survival Gerhartz et al.81 RAEB, RAEB-T, CMML LODAC + GM-CSF 14 15 16.8 months median survival Feldman et al.99 RA, RAEB, RAEB-T, CMML HHT 20 42* 7months median duration of CR Andreeff et al.99 All subtypes HMBA 8 2* 6.8 months median duration ofCR Silverman et al.90 RAEB, RAEB-T 5-Aza 12 4 14.7 months median dura ...
